Français

For Universal Life Investment Accounts

CI Global Health Sciences Corporate Class A

Sector Equity

As Of: Jan 31, 2024

Fund Objective

This fund’s objective is to obtain maximum long-term capital growth. It invests primarily in equity and equity-related securities of companies around the world that specialize in the health care or medical industry. This includes companies that provide goods and services to these companies and companies that the portfolio adviser believes would benefit from developments in the health sciences industry.

Asset Allocation

Asset Percent
US Equity 76.70%
International Equity 20.62%
Cash and Equivalents 2.68%

Sector Allocation

Sector Percent
Healthcare 91.81%
Exchange Traded Fund 4.42%
Cash and Cash Equivalent 2.68%
Consumer Services 1.09%

Geo Allocation

Region Percent
North America 79.32%
Europe 20.67%
Asia 0.00%
Other 0.01%

Top Holdings

Name Percent
Eli Lilly and Co 10.00%
Humana Inc 9.29%
UnitedHealth Group Inc 9.09%
Novo Nordisk A/S Cl B 7.78%
Merck & Co Inc 5.92%
AstraZeneca PLC 4.88%
Zoetis Inc Cl A 4.47%
SPDR S&P Biotech ETF (XBI) 4.42%
Abbvie Inc 3.89%
Stryker Corp 3.47%

Category

Sector Equity

General Info

Inception Date Jul 23, 1996
MER 2.34%
Total Assets
(in millions)
$142.07

UL Fees

Wave 33 or later
Life Dimensions (Low Fees) 1.00%
Life Dimensions 2.25%
Wealth Dimensions 1.00%
Wave 32 or earlier (2016 or earlier)
Life Dimensions 2.75%
Life Dimensions (Low Fees) 1.50%
UL Investment Loan Plan 2.75%
Ultimate Dimension 1.25%

Fund Management Company

CI Global Asset Management

Investment Style

This investment's style box characteristics are Large Growth.

Fund Growth

Period

Growth Summary

Table below lists the current growth and return for an investment of $10,000 at the fund's inception:

Investment Value $78,473.84
Rate of Return +684.74%
Values over period specified.

Legend

CI Global Health Sciences Corporate Class A

S&P/TSX Composite Index TR


Performance

1 Mth 3 Mth 6 Mth YTD 1 Yr 3 Yr 5 Yr 10 Yr Inception
Fund 2.5 6.0 5.6 2.5 7.9 0.5 4.2 3.2 7.8
S&P/TSX Composite Index TR 0.6 12.3 3.6 0.6 4.6 9.9 9.6 7.6 -
Quartile 3 4 3 3 3 3 4 4 -

Calendar Performance

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Fund 2.6 -1.2 -0.1 11.2 12.0 1.1 6.4 -19.1 14.1 19.6
S&P/TSX Composite Index TR 11.8 -5.8 25.1 5.6 22.9 -8.9 9.1 21.1 -8.3 10.6
Quartile 3 1 4 3 4 3 4 4 3 3

Volatility

Volatility: 5

Risk vs. Return

Period

CI Global Health Sciences Corporate Class A

Median

Other - Sector Equity

Risk & Tax Efficiency

3 Yr 5 Yr 10 Yr
Standard Deviation 10.19 14.06 15.62
Beta 0.34 0.53 0.59
Alpha -0.02 0.00 0.00
R-Squared 0.20 0.34 0.23
Sharpe Ratio -0.13 0.23 0.20
Sortino Ratio -0.28 0.24 0.13
Treynor -0.04 0.06 0.05
Tax Efficiency 50.72 81.45 73.18

Category

Sector Equity

General Info

Inception Date Jul 23, 1996
MER 2.34%
Total Assets
(in millions)
$142.07

UL Fees

Wave 33 or later
Life Dimensions (Low Fees) 1.00%
Life Dimensions 2.25%
Wealth Dimensions 1.00%
Wave 32 or earlier (2016 or earlier)
Life Dimensions 2.75%
Life Dimensions (Low Fees) 1.50%
UL Investment Loan Plan 2.75%
Ultimate Dimension 1.25%

Fund Management Company

CI Global Asset Management

Investment Style

This investment's style box characteristics are Large Growth.